Transaction · 0000950142-26-002518

Bokhari Raza

Bokhari Raza, CEO, reported a transaction classified as grant at Medicus Pharma Ltd. involving 2941176.000000 shares for an estimated $501470.51. Reported holdings after the transaction were 2941176.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACEO
MDCXMedicus Pharma Ltd.
Trade date
Sep 04, 2026
Filing date
Sep 08, 2026
View on SEC Insider profile
Estimated value$501kShares × reported price
Shares traded2.94M$0.17 per share
Holdings after2.94MDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

MDCX price since this filing

Daily closing prices, with the filing date and available return windows
MDCX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0000950142-26-002518
Common Shares, no par value
Transaction date
Sep 04, 2026
Filed Sep 08, 2026, 09:00 PM · 4d delay
Shares
2,941,176 sh
$0.17 per share
Estimated value
$501k
Computed from shares × price
Holdings after
2,941,176 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase
Filing-only score

-16 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • grant_or_award-22 points

    transaction_code = A

    Grant or award transactions are scheduled compensation, not discretionary.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The option was granted on September 4, 2026. The option is scheduled to vest quarterly in four equal installments over one year.

Original filing · 0000950142-26-002518
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

MDCX